Showing results (171-180 of 340) with videos related to

Sort By:
Pageof 34
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 28, 2012
Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) studyPaul A Smink, Hiddo J Lambers Heerspink, Ron T Gansevoort, et al.
Lancet (London, England)|November 9, 2010
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trialDick de Zeeuw, Rajiv Agarwal, Michael Amdahl, et al.
Clinical Chemistry|June 19, 2007
Apparent loss of urinary albumin during long-term frozen storage: HPLC vs immunonephelometryJacoline W Brinkman, Dick de Zeeuw, Hiddo J Lambers Heerspink, et al.
Atherosclerosis|January 8, 2004
C-reactive protein and microalbuminuria differ in their associations with various domains of vascular diseaseErik M Stuveling, Hans L Hillege, Stephan J L Bakker, et al.
Kidney International. Supplement|March 9, 2005
The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general populationRon T Gansevoort, Jacobien C Verhave, Hans L Hillege, et al.
Kidney International|March 23, 2012
Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockersHiddo J Lambers Heerspink, Frank A Holtkamp, Hans-Henrik Parving, et al.
Diabetes & Vascular Disease Research|September 22, 2018
Guidelines and clinical practice at the primary level of healthcare in patients with type 2 diabetes mellitus with and without kidney disease in five European countriesSusanne Eder, Johannes Leierer, Julia Kerschbaum, et al.
Kidney International|May 30, 2020
Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetesJingWei Li, Bruce Neal, Vlado Perkovic, et al.
European Journal of Clinical Pharmacology|May 25, 2005
Uptake of angiotensin II receptor blockers in the treatment of hypertensionJacoba P Greving, Petra Denig, Willem Jan van der Veen, et al.
Kidney & Blood Pressure Research|February 22, 2018
A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) - Study Design and Baseline CharacteristicsSusanne Eder, Johannes Leierer, Julia Kerschbaum, et al.
Pageof 34